Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1988-9-22
|
pubmed:abstractText |
During the period July 1983 through December 1984, aminoglycoside-resistant Acinetobacter calcoaceticus var anitratus (ACA) were isolated from 98 patients in a university hospital. Eighty-seven percent of patients (85/98) acquired aminoglycoside-resistant ACA in the intensive care unit (ICU) and 92% (90/98) of all initial isolates were from sputum. ICU patients with respiratory colonization/infection with aminoglycoside-resistant ACA were compared with matched ICU controls with other gram-negative rods in sputum. Compared with controls, the duration of ICU stay prior to colonization/infection with aminoglycoside-resistant ACA was significantly longer for cases (14.7 days v 5.9 days, P = 0.002). Although exposures to devices and procedures were not significantly different for the two groups, cases received respiratory therapy significantly longer than did controls (14.7 days v 6.6 days, P = 0.006). Prior to isolation of aminoglycoside-resistant ACA in sputum, cases received more cephalosporins than did controls (1.9 v 1.2, P = 0.018); aminoglycoside usage in the two groups was comparable but cases tended to have received aminoglycoside for longer durations before colonization/infection than had controls (9.0 days v 6.1 days, P = 0.08). Following sputum isolation of ACA, 6 of 22 cases developed ACA bacteremia compared with bacteremia in 2 of 22 controls. We conclude that factors predisposing to colonization/infection with aminoglycoside-resistant ACA were extended ICU care, prolonged respiratory therapy, and prior therapy with cephalosporins and aminoglycoside. In addition, ACA may be a more common cause of secondary bacteremia than previously appreciated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0899-823X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
302-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3403939-Acinetobacter,
pubmed-meshheading:3403939-Acinetobacter Infections,
pubmed-meshheading:3403939-Aminoglycosides,
pubmed-meshheading:3403939-Anti-Bacterial Agents,
pubmed-meshheading:3403939-Cross Infection,
pubmed-meshheading:3403939-Drug Resistance, Microbial,
pubmed-meshheading:3403939-Female,
pubmed-meshheading:3403939-Humans,
pubmed-meshheading:3403939-Intensive Care Units,
pubmed-meshheading:3403939-Male,
pubmed-meshheading:3403939-Microbial Sensitivity Tests,
pubmed-meshheading:3403939-Middle Aged,
pubmed-meshheading:3403939-Respiratory System,
pubmed-meshheading:3403939-Respiratory Tract Infections
|
pubmed:year |
1988
|
pubmed:articleTitle |
Nosocomial respiratory tract colonization and infection with aminoglycoside-resistant Acinetobacter calcoaceticus var anitratus: epidemiologic characteristics and clinical significance.
|
pubmed:affiliation |
Department of Medicine, Wake Forest University Medical Center, Winston-Salem, North Carolina 27103.
|
pubmed:publicationType |
Journal Article
|